Supernus Pharmaceuticals, Inc. (SUPN)
50.86
-0.49
(-0.95%)
USD |
NASDAQ |
Feb 20, 16:00
50.81
-0.05
(-0.10%)
After-Hours: 20:00
Supernus Pharmaceuticals Market Cap : 2.916B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 28.18B |
| Catalyst Pharmaceuticals, Inc. | 2.987B |
| Oncotelic Therapeutics, Inc. | 20.58M |
| Vertex Pharmaceuticals, Inc. | 121.15B |
| Krystal Biotech, Inc. | 7.592B |
Market Cap Related Metrics
| PS Ratio | 4.208 |
| Price to Book Value | 2.778 |
| Price to Free Cash Flow | 40.53 |
| Price | 50.86 |
| Earnings Yield | -0.67% |